Latest News
UCSF Team Studying Genomics of Rare Cancers With Geographic Hotspots
December 7, 2017. from GenomeWeb.com.
A research team at the University of California, San Francisco aims to study cancer genomes from tumor types that are globally rare but have geographic hotspots where incidence rates soar. As a first part of such work, the team has sequenced the whole genomes and transcriptomes of 61 esophageal tumors from patients in Tanzania. The UCSF team has been collaborating with Muhimbili University of Health and Allied Sciences and the Ocean Road Cancer Institute in Dar es Salaam, Tanzania for the project, which is part of UCSF's Global Cancer Program launched this fall. In addition, NantWorks donated sequencing services. > continue to full article
The MUHAS-UCSF Esophageal Cancer Research Team is co-lead by Dr. Katherine Van Loon (second from left) and Dr. Elia Mmbaga (second from right).
November 17, 2017. from cancer.ucsf.edu
In September, Katherine Van Loon, MD, MPH, assistant professor in hematology/oncology and director of the HDFCCC Global Cancer Program, led a group of UCSF faculty and trainees to Tanzania to meet with stakeholders at the Muhimbili University of Health and Allied Sciences (MUHAS) and Ocean Road Cancer Institute (ORCI) in Dar es Salaam, Tanzania. Below, Van Loon talks about the trip, and UCSF residents offer their thoughts on this unique opportunity.
>read more
OUR MISSION
To reduce the global cancer burden through innovation, education, and collaboration.
OUR OBJECTIVES
- To perform innovative research that addresses the disparate burden of cancer in LMICs.
- To provide education, research training, and mentorship for trainees and early career faculty in LMICs and at UCSF focused on global cancer research.
- To foster collaborations between UCSF and healthcare systems in LMICs to sustainably impact the global cancer burden.
OUR PARTNERSHIPS
